Last reviewed · How we verify

Targeted Systemic Therapy — Competitive Intelligence Brief

Targeted Systemic Therapy (Targeted Systemic Therapy) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Oncology.

phase 3 Oncology Small molecule Live · refreshed every 30 min

Target snapshot

Targeted Systemic Therapy (Targeted Systemic Therapy) — Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA). Targeted Systemic Therapy is a cancer treatment designed to selectively target and destroy malignant cells while minimizing damage to healthy tissue.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Targeted Systemic Therapy TARGET Targeted Systemic Therapy Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) phase 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Targeted Systemic Therapy — Competitive Intelligence Brief. https://druglandscape.com/ci/targeted-systemic-therapy. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: